ArticleCell death & disease2026
LncPTEC mediated homocysteine accumulation elevates oxidative stress via UBQLN1-dependent MTHFD1 ubiquitination in DKD.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Not a Messenger, but Lots to Say: New Insights on Long Noncoding RNAs in the Kidney.Acta physiologica (Oxford, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and chronic kidney disease. Oxidative stress, a key driver of renal fibrosis and a hallmark of DKD pathological changes, has been extensively studied for its role in DKD progression. However, its specific mechanisms remain unclear. Here, we show that homocysteine (Hcy) accumulation in proximal tubular epithelial cells (PTECs) is a significant contributor to mitochondrial oxidative stress in DKD. Through single-cell RNA sequencing (scRNA-seq) screening, we identify lncPTEC, a DKD-associated long non-coding RNA (lncRNA) from the PTEC cluster. Notably, we find that upregulated lncPTEC correlates with elevated albuminuria in DKD patients and exacerbates mitochondrial oxidative stress, epithelial-mesenchymal transition (EMT) and renal tubular fibrosis both in vitro and in vivo. Mechanistically, lncPTEC is transcriptionally upregulated by the transcription factor specificity protein 1 (SP1) under hyperglycemic conditions. Furthermore, lncPTEC directly interacts with the established key factor of Hcy metabolism, methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), promoting its ubiquitination and degradation via the ubiquitination-related protein UBQLN1. This process leads to Hcy accumulation, mitochondrial oxidative stress, and subsequent DKD progression. Hence, our findings elucidate the role of the lncPTEC/MTHFD1 axis in Hcy-mediated mitochondrial oxidative stress, offering potential diagnostic biomarkers and therapeutic targets for DKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.